Skip to main content
In stock | Targeted Therapy (Investigational)

Tulmimetostat

Oncology Type Both (Solid & Hematologic)
Drug Class / Mechanism Dual EZH2/EZH1 Inhibitor
No Image
Description

Tulmimetostat is classified as a Dual EZH2/EZH1 Inhibitor, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Investigational)
Oncology Type Both (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3